Exploring the therapeutic convergence of meditation, psychedelics, and MDMA
Jacob T. Dines
Journal of Psychedelic Studies April 17, 2025 DOI: 10.1556/2054.2025.00435 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Narrative and theoretical review Peer reviewed |
|---|---|
| Topics | MDMA Meditation |
| Keywords | Emotional regulation Empathy Reduced distress Mental health Psychedelic-assisted therapy: psychedelics MDMA-Assisted Therapy Therapeutic insights New approach Meditation: meditation Neuroscience: neuroplasticity Brain networks Convergence Sustained positive results |
| Key findings | Proposes that integrating meditation with psychedelic or MDMA-assisted therapy may enhance therapeutic outcomes by leveraging overlapping neurobiological and psychological mechanisms. |
Abstract
AbstractBackground and aimsPsychedelic and MDMA-assisted psychotherapy are at the forefront of new treatment models for mental illnesses such as PTSD and depression, as well as improving well-being. Mindfulness meditation and loving-kindness meditation have also gained research traction, showing promise for enhancing emotional regulation and psychological well-being. This paper explores the therapeutic convergence of these modalities, highlighting their neurobiological, psychological, and phenomenological overlap, and suggesting potential bidirectional synergy as a foundation for psychedelic or MDMA-assisted therapy.MethodsA narrative and theoretical review of the current literature was conducted, examining the neurobiological, psychological, and phenomenological effects of MDMA, psychedelics, and meditation. Studies focusing on their potential synergy and mechanisms of action were prioritized and used as a backing for a theoretical framework.ResultsPsychedelics may improve psychological flexibility, prosocial behaviors, empathy, and neuroplasticity. Meditation research suggests similar benefits, including enhanced decentering capacity, emotional regulation, and well-being. Both modalities influence overlapping neural circuitry, particularly the amygdala, hippocampus, and default mode network. Integrating meditation with MDMA or psychedelic-assisted therapy may stabilize insights gained during altered states of consciousness, promote sustained therapeutic benefits, and minimize distress during therapy.ConclusionsThe convergence of meditation and psychedelics or MDMA-assisted therapy is a novel and promising approach for enhancing mental health treatments. Future research should investigate structured protocols combining these modalities, focusing on optimizing “set and setting” and long-term integration practices.
Comparable studies
Other narrative reviews on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Human Pharmacology of MDMA | 2004 | Review | |
| Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research | 2001 | Review | |
| 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans | 1994 | Review | |
| (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals | 2000 | Review | |
| Amphetamine toxicities | 2010 | Review |
Citations in the library
Cites 68
- A default mode of brain function Proceedings of the National Academy of Sciences January 16, 2001
- Mechanisms of mindfulness Journal of Clinical Psychology December 29, 2005
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Meditation experience is associated with differences in default mode network activity and connectivity Proceedings of the National Academy of Sciences November 23, 2011
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
and 63 more in the library